Of the leading “neglected tropical diseases” (NTDs) in the world leishmaniasis is one of the most prominent, if not number one. But because it almost always affects poor people in rural areas of the tropics, there is little economic incentive for pharmaceutical companies to develop vaccines or treatments.
